Topiramate

NDC 72888-230 · Advagen Pharma Ltd

Generic nameTopiramate

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength50 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

72888-230-05 — 500 CAPSULE in 1 BOTTLE (72888-230-05)

72888-230-12 — 120 CAPSULE in 1 BOTTLE (72888-230-12)

72888-230-30 — 30 CAPSULE in 1 BOTTLE (72888-230-30)

72888-230-60 — 60 CAPSULE in 1 BOTTLE (72888-230-60)

72888-230-67 — 240 CAPSULE in 1 BOTTLE (72888-230-67)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72603-124 — topiramate, 72789-004 — Topiramate, 72789-443 — Topiramate, 72789-471 — Topiramate, 72865-313 — Topiramate, 72865-314 — Topiramate, 72865-315 — Topiramate, 72865-316 — Topiramate, 72888-228 — Topiramate, 72888-229 — Topiramate, 76282-278 — Topiramate, 76282-279 — Topiramate, 76282-280 — Topiramate, 76282-281 — Topiramate, 76420-276 — Topiramate, 76420-278 — Topiramate, 76420-279 — Topiramate, 76420-280 — Topiramate, 80425-0092 — Topiramate, 80425-0195 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels